Philip Nickson
General Counsel, Monte Rosa Therapeutics.
Companies
- Monte Rosa TherapeuticsChief Business & Legal Officer Jun 5, 2024 to now1
- Monte Rosa TherapeuticsGeneral counsel Mar 2, 2022 to Jan 4, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Monte Rosa Therapeutics GLUE55,000 shares3$556.6K at $10.12Apr 9, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 9, 2026Sold 5,845 shares at $17.69 of Monte Rosa Therapeutics3
- Jan 5, 2026Sold 3,155 shares at $15.17 of Monte Rosa Therapeutics4
- Jan 2, 2026Granted 28,000 shares of Monte Rosa Therapeutics4
- Jan 2, 2025Granted 36,000 shares of Monte Rosa Therapeutics5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jan 5, 2026
- 5SEC EDGARForm 4 filed Jan 6, 2025